5093.0 Late Breaker: 2009 H1N1 Influenza Ė Status Update and Lessons Learned from CDC

Wednesday, November 11, 2009: 10:30 AM
In April 2009, a novel strain of influenza A was identified in Mexico and North America, and the first U.S. cases were detected later that same month. Since then, the 2009 H1N1 influenza virus has spread from person-to-person, resulting in the first influenza pandemic since 1968-69. Since the spring, millions of people have been infected and thousands of deaths have resulted worldwide. In contrast to seasonal influenza which disproportionately affects people older than 65 years of age, 2009 H1N1 influenza has caused greater disease burden in people younger than 25 years of age. The emergence of this novel virus has required a prompt, coordinated, and robust response from all levels of government and the private sector. At the Federal level, HHS and CDC have taken measures to develop strategies and support preparedness and response activities based on four pillars: 1) Epidemiology & Surveillance, 2) Vaccine, 3) Community Measures, and 4) Communications. As part of this response, CDCís primary objectives have been to 1) reduce illness and death associated with 2009 H1N1 influenza, 2) minimize the impact to society, and 3) place the greatest amount of effort into activities that will ultimately have the greatest public health impact. During this session, representatives from CDCís H1N1 task forces will review the current situation and discuss some of the observed lessons from the current pandemic.
Session Objectives: Discuss common challenges and capability gaps revealed by the 2009 H1N1 influenza pandemic. Describe the strategies employed to both respond to 2009 H1N1 influenza and mitigate the impact of recommended response measures. Identify key lessons and future opportunities to improve public health readiness and response.

10:30 AM
10:50 AM
CDC H1N1 Vaccine Task Force
CAPT Jay Butler, MD
11:10 AM
CDC H1N1 Community Mitigation Task Force
Richard A. Schieber, MD, MPH
11:30 AM
CDC H1N1 Joint Information Center
Marsha Vanderford, PhD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: APHA-Special Sessions

See more of: APHA-Special Sessions